We extend our model to include fitness costs on the resistant parasite in several stages of the life cycle. We distinguish here not only between the transmission probabilities of the different immunity classes (as we did earlier), but also between the resistant and the wild type. Thus, c w,i denotes the transmission probability of hosts infected with wild type in immunity class i, and c r ,i denotes the transmission probability of hosts infected with the resistant parasite in immunity class i.
denotes the transmission probability of hosts infected with wild type in immunity class i, and c r ,i denotes the transmission probability of hosts infected with the resistant parasite in immunity class i. 
Our assumptions are:
1) The change in the transmission probabilities from immunity class to immunity class stays at the same ratio for both resistant and wild type. 2) The treatment level does not increase as clinical immunity is gained:
We use the following notations to define the conditions for the valley phenomenon:
Note the following inequality, which will be useful in several stages:
The conditions for the valley phenomenon in the three-class model are (in red): Thus, either the clearance rate decreases from class to class in the wild type, leading to a decrease in the clearance rate of the resistant type. Or, alternatively, if clearance rate of the wild type does not decrease with gain of immunity, there must be a cost of resistance on the resistant parasite that clears it more slowly in the higher immunity classes, and note that in this case, this cost of resistance cannot be linear (i.e., κ w,3 = κ w,2 and κ r ,3 << κ r ,2 ).
CASE STUDY II
Now assume that ∀i : c w,i > c r ,i such that there may be a fitness cost on the resistant parasite in the probability of transmission:
we need :
we will return to this later in subsection iv ii) for 
